ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
NickEegz
|
1.1K |
294K |
8 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
1.1K
|
294K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
NickEegz
|
1.1K |
294K |
7 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
1.1K
|
294K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
NickEegz
|
311 |
76K |
4 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
311
|
76K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
$1 party
|
|
NickEegz
|
3 |
1.1K |
2 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
3
|
1.1K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
NickEegz
|
114 |
32K |
3 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
114
|
32K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
NickEegz
|
209 |
49K |
1 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
209
|
49K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
NickEegz
|
209 |
49K |
6 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
209
|
49K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: EGM Shareholder Presentation
|
|
NickEegz
|
45 |
12K |
8 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
45
|
12K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
NickEegz
|
323 |
74K |
16 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
323
|
74K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
NickEegz
|
323 |
74K |
16 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
323
|
74K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Options Offer to Existing Listed Option Holders
|
|
NickEegz
|
79 |
16K |
2 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
79
|
16K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Canine Oncology Data Supports Progression to Registration
|
|
NickEegz
|
91 |
18K |
21 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
91
|
18K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Louie the Beagle surpasses one year on MPL
|
|
NickEegz
|
37 |
7.5K |
3 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
37
|
7.5K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Biomarkers and Pharmacodynamics Results
|
|
NickEegz
|
396 |
82K |
14 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
396
|
82K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Biomarkers and Pharmacodynamics Results
|
|
NickEegz
|
396 |
82K |
19 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
396
|
82K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
Interactive AGM Yes/No vote
|
|
NickEegz
|
87 |
12K |
8 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
87
|
12K
|
8
|
|
ASX - By Stock
|
NOR |
Re:
Ann: Ceasing to be a substantial holder
|
|
NickEegz
|
317 |
50K |
2 |
03/06/22 |
03/06/22 |
ASX - By Stock
|
317
|
50K
|
2
|
|
ASX - By Stock
|
NOR |
Re:
Ann: Ceasing to be a substantial holder
|
|
NickEegz
|
317 |
50K |
2 |
03/06/22 |
03/06/22 |
ASX - By Stock
|
317
|
50K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Clinical Trials Interview June 2022
|
|
NickEegz
|
16 |
4.2K |
8 |
03/06/22 |
03/06/22 |
ASX - By Stock
|
16
|
4.2K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Clinical Trials Update
|
|
NickEegz
|
99 |
21K |
5 |
29/05/22 |
29/05/22 |
ASX - By Stock
|
99
|
21K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Clinical Trials Update
|
|
NickEegz
|
99 |
21K |
5 |
26/05/22 |
26/05/22 |
ASX - By Stock
|
99
|
21K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Clinical Trials Update
|
|
NickEegz
|
99 |
21K |
7 |
26/05/22 |
26/05/22 |
ASX - By Stock
|
99
|
21K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Clinical Trials Update
|
|
NickEegz
|
99 |
21K |
1 |
24/05/22 |
24/05/22 |
ASX - By Stock
|
99
|
21K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Clinical Trials Update
|
|
NickEegz
|
99 |
21K |
6 |
24/05/22 |
24/05/22 |
ASX - By Stock
|
99
|
21K
|
6
|
|
ASX - By Stock
|
NOR |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
NickEegz
|
207 |
23K |
3 |
10/01/22 |
10/01/22 |
ASX - By Stock
|
207
|
23K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Monsoon Presentation
|
|
NickEegz
|
72 |
13K |
2 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
72
|
13K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Change of Director's Interest Notice x 4
|
|
NickEegz
|
1 |
881 |
7 |
09/11/21 |
09/11/21 |
ASX - By Stock
|
1
|
881
|
7
|
|
ASX - By Stock
|
PAA |
Re:
The Home Stretch
|
|
NickEegz
|
360 |
81K |
3 |
12/10/21 |
12/10/21 |
ASX - By Stock
|
360
|
81K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
The Home Stretch
|
|
NickEegz
|
360 |
81K |
8 |
16/09/21 |
16/09/21 |
ASX - By Stock
|
360
|
81K
|
8
|
|
ASX - By Stock
|
NOR |
Re:
Ann: Appendix 4E and Annual Report to Shareholders
|
|
NickEegz
|
308 |
35K |
4 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
308
|
35K
|
4
|
|
ASX - By Stock
|
NOR |
Re:
Positive news flow
|
|
NickEegz
|
4.6K |
655K |
5 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
4.6K
|
655K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
The Home Stretch
|
|
NickEegz
|
360 |
81K |
8 |
29/08/21 |
29/08/21 |
ASX - By Stock
|
360
|
81K
|
8
|
|
ASX - By Stock
|
NOR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
NickEegz
|
587 |
75K |
5 |
28/08/21 |
28/08/21 |
ASX - By Stock
|
587
|
75K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Change of Director's Interest Notice
|
|
NickEegz
|
7 |
1.9K |
9 |
24/08/21 |
24/08/21 |
ASX - By Stock
|
7
|
1.9K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Virtual Investor Briefing
|
|
NickEegz
|
73 |
16K |
2 |
12/08/21 |
12/08/21 |
ASX - By Stock
|
73
|
16K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Virtual Investor Briefing
|
|
NickEegz
|
73 |
16K |
1 |
12/08/21 |
12/08/21 |
ASX - By Stock
|
73
|
16K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Virtual Investor Briefing
|
|
NickEegz
|
73 |
16K |
3 |
12/08/21 |
12/08/21 |
ASX - By Stock
|
73
|
16K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust files patent for monepantel in viral diseases
|
|
NickEegz
|
48 |
9.3K |
12 |
22/07/21 |
22/07/21 |
ASX - By Stock
|
48
|
9.3K
|
12
|
|
ASX - By Stock
|
NOR |
Re:
Ann: CEO AGM Presentation
|
|
NickEegz
|
7 |
1.8K |
5 |
30/11/20 |
30/11/20 |
ASX - By Stock
|
7
|
1.8K
|
5
|
|
ASX - By Stock
|
NOR |
Re:
no one cares but...
|
|
NickEegz
|
3 |
1.2K |
6 |
06/11/20 |
06/11/20 |
ASX - By Stock
|
3
|
1.2K
|
6
|
|
ASX - By Stock
|
NOR |
Re:
Ann: Quarterly Activities and Appendix 4C Cashflow Report
|
|
NickEegz
|
86 |
10K |
5 |
30/10/20 |
30/10/20 |
ASX - By Stock
|
86
|
10K
|
5
|
|
ASX - By Stock
|
NOR |
Re:
Ann: Spark goes live with Norwood's on premises visual voicemail
|
|
NickEegz
|
90 |
16K |
5 |
20/10/20 |
20/10/20 |
ASX - By Stock
|
90
|
16K
|
5
|
|
ASX - By Stock
|
NOR |
Re:
Positive news flow
|
|
NickEegz
|
4.6K |
655K |
6 |
08/10/20 |
08/10/20 |
ASX - By Stock
|
4.6K
|
655K
|
6
|
|
ASX - By Stock
|
NOR |
Re:
Positive news flow
|
|
NickEegz
|
4.6K |
655K |
3 |
07/10/20 |
07/10/20 |
ASX - By Stock
|
4.6K
|
655K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
HC PAA SH Volume
|
|
NickEegz
|
180 |
40K |
3 |
04/10/20 |
04/10/20 |
ASX - By Stock
|
180
|
40K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Annual Report
|
|
NickEegz
|
61 |
14K |
16 |
21/09/20 |
21/09/20 |
ASX - By Stock
|
61
|
14K
|
16
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Covi-Pantel . NZ Trader Release
|
|
NickEegz
|
1.4K |
311K |
2 |
16/09/20 |
16/09/20 |
ASX - By Stock
|
1.4K
|
311K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Elanco Option Update
|
|
NickEegz
|
194 |
49K |
14 |
09/09/20 |
09/09/20 |
ASX - By Stock
|
194
|
49K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Covi-Pantel . NZ Trader Release
|
|
NickEegz
|
1.4K |
311K |
6 |
09/09/20 |
09/09/20 |
ASX - By Stock
|
1.4K
|
311K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Elanco Option Update
|
|
NickEegz
|
194 |
49K |
12 |
09/09/20 |
09/09/20 |
ASX - By Stock
|
194
|
49K
|
12
|
|